COPD

The Pharmacy Times® Chronic Obstructive Pulmonary Disease (COPD) Disease Resource Center is a comprehensive resource for clinical news and expert insights on a group of diseases that cause airflow blockage and breathing-related problems, including emphysema and chronic bronchitis.

GOLD Guidelines Provide Recommendations on Managing COPD

November 16, 2022

Article

Pivotal resource helps health care professionals diagnose, manage, and prevent this group of lung diseases.

Aclidinium Bromide/Formoterol, Aclidinium Bromide May Be Effective for Severe Stable COPD

October 28, 2022

Article

Covis announced positive topline results for 2 new medications that can treat patients with moderate to severe stable chronic obstructive pulmonary disease.

Study: Health Care Professionals Should Recommend Herpes Zoster Vaccine for Patients With COPD

October 18, 2022

Article

A short 5-minute educational video may improve health care professionals’ knowledge about the herpes zoster vaccine, guidelines, and what patients should receive it.

Research Shows Supporting Gut-Lung Axis Can Prevent Lung Disease

July 07, 2022

Article

People have been taking probiotics to support digestive health for centuries, but researchers in the pulmonary field have turned their attention toward how microbiome science can be used to support the lungs.

Daily Medication Pearl: Budesonide, Glycopyrrolate, and Formoterol Fumarate (Breztri)

April 12, 2022

Article

Breztri is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease.

Optimizing Care for Orphan Diseases With Pulmonary Issues During COVID-19 Pandemic

April 05, 2022

Article

The value of a patient-first approach and telehealth for addressing the complex health care coordination needs of patients with rare pulmonary diseases has never been more critical than during the COVID-19 pandemic.

FDA Approves Symbicort Generic to Treat Asthma and COPD

March 17, 2022

Article

Agency hopes green light for complex drug device combination improves competition and access more affordable medications.

Daily Medication Pearl: Fluticasone/Salmeterol (Wixela)

January 10, 2022

Article

Wixela Inhub is indicated for the treatment of asthma in patients 4 years of age and older and maintenance treatment of patients with chronic obstructive pulmonary disease.

Daily Medication Pearl: Fluticasone Furoate and Vilanterol (Breo Ellipta)

January 07, 2022

Article

Breo Ellipta is indicated for long-term, once-daily, maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease.

Daily Medication Pearl: Advair Diskus (Fluticasone and Salmeterol)

January 03, 2022

Article

Advair Diskus is indicated for the maintenance treatment of asthma and chronic obstructive pulmonary disease.